Service de rhumatologie

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


902 publications

... | 2016 | 2015 | 2014 | 2013 | 2012 | ...
 
Dual-Energy Computed Tomography-Based Molecular Imaging of Cholesterol Deposits in Achilles Tendon Xanthomatosis.
Hajdu S.D., Omoumi P., Baalbaki R., Crevoisier X., Letovanec I., So A.K., Becce F., 2016/07. Arthritis and Rheumatology (hoboken, N.j.), 68 (7) p. 1687. Peer-reviewed.
 
Interleukin-6 and chondrocyte mineralisation act in tandem to promote experimental osteoarthritis.
Nasi S., So A., Combes C., Daudon M., Busso N., 2016/07. Annals of the rheumatic diseases, 75 (7) pp. 1372-1379. Peer-reviewed.
 
Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
Villiger P.M., Adler S., Kuchen S., Wermelinger F., Dan D., Fiege V., Bütikofer L., Seitz M., Reichenbach S., 2016/05/07. Lancet, 387 (10031) pp. 1921-1927. Peer-reviewed.
 
A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX.
McCloskey E.V., Odén A., Harvey N.C., Leslie W.D., Hans D., Johansson H., Barkmann R., Boutroy S., Brown J., Chapurlat R. et al., 2016/05. Journal of bone and mineral research, 31 (5) pp. 940-948. Peer-reviewed.
 
Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports.
Aubry-Rozier B., Gonzalez-Rodriguez E., Stoll D., Lamy O., 2016/05. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 27 (5) pp. 1923-1925. Peer-reviewed.
 
Treat-to-target (T2T) recommendations for gout.
Kiltz U., Smolen J., Bardin T., Cohen Solal A., Dalbeth N., Doherty M., Engel B., Flader C., Kay J., Matsuoka M. et al., 2016/04. Annals of the rheumatic diseases, 76 (4) pp. 632-638. Peer-reviewed.
 
Les spondyloarthropathies en 2015 [Spondylarthropathies in 2015]
So A., Gabay C., 2016/03/09. Revue medicale suisse, 12 (509) p. 483.
 
Nouveaux traitements biologiques et synthétiques de fond pour les spondylarthropathies [New synthetic and biologic treatments for spondylarthritis]
Zufferey P., 2016/03/09. Revue medicale suisse, 12 (509) pp. 512,514-516.
 
Spondyloarthropathies: traitements conventionnels et anti-TNF [Spondylarthropathies: conventional treatments and anti-TNF]
Dumusc A., So A., 2016/03/09. Revue medicale suisse, 12 (509) pp. 507-508,510-511.
 
Predictors of trabecular bone score in school children.
Shawwa K., Arabi A., Nabulsi M., Maalouf J., Salamoun M., Choucair M., Hans D., El-Hajj Fuleihan G., 2016/02. Osteoporosis international, 27 (2) pp. 703-710. Peer-reviewed.
 
Clinician and patient-reported outcomes are associated with psychological factors in chronic shoulder pain patients.
Luthi F., Wolfensberger A., Vuistiner P., Konzelmann M., Plomb-Holmes C., Leger B., 2016. Annals of Physical and Rehabilitation Medicine, 59S pp. e63. Peer-reviewed.
 
Core Outcome Measure Index for low back patients: do we miss anxiety and depression?
Cedraschi C., Marty M., Courvoisier D.S., Foltz V., Mahieu G., Demoulin C., Gierasimowicz Fontana A., Norberg M., de Goumoëns P., Rozenberg S. et al., 2016. European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 25 (1) pp. 265-274. Peer-reviewed.
Guidelines for the treatment of gout: a Swiss perspective.
Wüthrich H., Alromaih F., So A., 2016. Swiss Medical Weekly, 146 pp. w14341.
 
How much does the Dallas Pain Questionnaire score have to improve to indicate that patients with chronic low back pain feel better or well?
Marty M., Courvoisier D., Foltz V., Mahieu G., Demoulin C., Gierasimowicz A., Norberg M., de Goumoëns P., Cedraschi C., Rozenberg S. et al., 2016. European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 25 (1) pp. 304-309. Peer-reviewed.
 
Infiltrations intra-articulaires en rhumatologie : mise au point
Chevalier-Ruggeri P., Zufferey P., 2016/01. Revue Médicale Suisse, 12 pp. 90-94.
 
IRM dans le diagnostic des spondyloarthrites axiales: utilité et pièges diagnostiques [MRI of axial spondyloarthritis: diagnostic role and pitfalls].
Omoumi P., Larbi A., Zufferey P., So A., Becce F., Vande Berg B., Malghem J., 2016. Revue Médicale Suisse, 12 (509) pp. 495-6, 498-502. Peer-reviewed.
 
Is it possible to determine the minimal clinically important difference (MCID) of the French version of the hand function sort (HFS-F) for patients hospitalized in musculoskeletal rehabilitation?
Benhissen Z., Konzelmann M., Vuistiner P., Leger B., Luthi F., Benaim C., 2016. Annals of Physical and Rehabilitation Medicine, 59S pp. e60. Peer-reviewed.
 
Neuroarthropathy of the foot revealing primary systemic amyloidosis: case report and literature review.
Andrei I.A., Kuntzer T., Lobrinus J.A., Jaccard A., Zufferey P., 2016. Clinical Rheumatology, 35 (2) pp. 535-539.
Osteogenesis imperfecta: from diagnosis and multidisciplinary treatment to future perspectives.
Bregou Bourgeois A., Aubry-Rozier B., Bonafé L., Laurent-Applegate L., Pioletti D.P., Zambelli P.Y., 2016. Swiss medical weekly, 146 pp. w14322. Peer-reviewed.
 
Potential blindness in children of patients with hereditary bone disease.
Kheir V., Munier F.L., Aubry-Rozier B., Schorderet D.F., 2016. Osteoporosis International : A Journal Established As Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa, 27 (2) pp. 841-844. Peer-reviewed.
 
Promoting physical activity: What do we have available to motivate our patients?
Saubade M., Karatzios C., Besson C., Farasse A.C., Charles B., Gremion G., 2016. Annals of Physical and Rehabilitation Medicine, 59S pp. e54-e55.
 
Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout.
Rasheed H., Phipps-Green A.J., Topless R., Smith M.D., Hill C., Lester S., Rischmueller M., Janssen M., Jansen T.L., Joosten L.A. et al., 2016. Rheumatology (oxford, England), 55 (8) pp. 1421-1430. Peer-reviewed.
Sodium Thiosulfate Prevents Chondrocyte Mineralization and Reduces the Severity of Murine Osteoarthritis.
Nasi S., Ea H.K., Lioté F., So A., Busso N., 2016. PloS one, 11 (7) pp. e0158196. Peer-reviewed.
The Toll-Like Receptor 4 (TLR4) Variant rs2149356 and Risk of Gout in European and Polynesian Sample Sets.
Rasheed H., McKinney C., Stamp L.K., Dalbeth N., Topless R.K., Day R., Kannangara D., Williams K., Smith M., Janssen M. et al., 2016. Plos One, 11 (1) pp. e0147939. Peer-reviewed.
 
Trabecular bone score in kidney transplant recipients.
Naylor K.L., Lix L.M., Hans D., Garg A.X., Rush D.N., Hodsman A.B., Leslie W.D., 2016. Osteoporosis International : A Journal Established As Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa, 27 (3) pp. 1115-1121. Peer-reviewed.
 
Trabecular Bone Score in Patients With Chronic Glucocorticoid Therapy-Induced Osteoporosis Treated With Alendronate or Teriparatide.
Saag K.G., Agnusdei D., Hans D., Kohlmeier L.A., Krohn K.D., Leib E.S., MacLaughlin E.J., Alam J., Simonelli C., Taylor K.A. et al., 2016. Arthritis and Rheumatology (hoboken, N.j.), 68 (9) pp. 2122-2128. Peer-reviewed.
 
Trabecular bone score in type 1 diabetes--a cross-sectional study.
Neumann T., Lodes S., Kästner B., Lehmann T., Hans D., Lamy O., Müller U.A., Wolf G., Sämann A., 2016. Osteoporosis International : A Journal Established As Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa, 27 (1) pp. 127-133. Peer-reviewed.
 
Why better treatment of gout is needed.
So A.K., 2016. Clinical and Experimental Rheumatology, 34 (4 Suppl 98) pp. 63-65.
 
The risk factors for fractures and trabecular bone-score value in patients with endogenous Cushing's syndrome.
Belaya Z.E., Hans D., Rozhinskaya L.Y., Dragunova N.V., Sasonova N.I., Solodovnikov A.G., Tsoriev T.T., Dzeranova L.K., Melnichenko G.A., Dedov I.I., 2015/12. Archives of Osteoporosis, 10 (1) p. 44. Peer-reviewed.
A prospective evaluation of ultrasound as a diagnostic tool in acute microcrystalline arthritis.
Zufferey P., Valcov R., Fabreguet I., Dumusc A., Omoumi P., So A., 2015/07/22. Arthritis research & therapy, 17 p. 188. Peer-reviewed.
 
Nouveautés dans l'ostéogenèse imparfaite: de la recherche à la prise en charge multidisciplinaire [News in osteogenesis imperfecta: from research to clinical management]
Aubry-Rozier B., Unger S., Bregou A., Freymond Morisod M., Vaswani A., Scheider P., Bonafé L., 2015/03/18. Revue medicale suisse, 11 (466) pp. 657-658,660-662.
Dual-energy computed tomography molecular imaging of pigmented villonodular synovitis.
Becce F., Federau C., Letovanec I., Grandjean A., So A.K., Rüdiger H.A., 2015/03. Rheumatology, 54 (3) p. 457. Peer-reviewed.
 
Artérite de Horton: recommandations Lausannoises de prise en charge [Giant cell arteritis: guidelines of the University Hospital of Lausanne].
Tsetsou S., Michel P., Ribi C., Hirt L., Kawasaki A., Hugli O., De Leval L., Bart P.A., Waeber G., Meuli R. et al., 2015/02. Revue Médicale Suisse, 11 (461) pp. 411-417.
 
A 19-year-old woman with polyarthritis, anterior uveitis and coronary vasculitis: A case of adult Kawasaki disease.
D'Angelo F., Varisco P.A., So A., Taponnier M., Zufferey P., 2015. Joint, Bone, Spine, 82 (6) pp. 468-470.
 
AA amyloidosis treated with tocilizumab: case series and updated literature review.
Courties A., Grateau G., Philippe P., Flipo R.M., Astudillo L., Aubry-Rozier B., Fabreguet I., Fahd W., Fain O., Guggenbuhl P. et al., 2015. Amyloid, 22 (2) pp. 84-92. Peer-reviewed.
 
Adjusting fracture probability by trabecular bone score.
McCloskey E.V., Odén A., Harvey N.C., Leslie W.D., Hans D., Johansson H., Kanis J.A., 2015. Calcified Tissue International, 96 (6) pp. 500-509. Peer-reviewed.
 
Anti-tumor necrosis factor drug survival in axial spondyloarthritis is independent of the classification criteria.
Zufferey P., Ghosn J., Becce F., Ciurea A., Aubry-Rozier B., Finckh A., So A.K., 2015. Rheumatology International, 35 (2) pp. 295-302. Peer-reviewed.
 
Bariatric surgery associated with percutaneous auricular vagal stimulation: A new prospective treatment on weight loss.
Kassir R., Barthelemy J.C., Roche F., Blanc P., Zufferey P., Galusca B., Perrot J.L., Garcin A., Charier D., Tiffet O., 2015. International Journal of Surgery, 18 pp. 55-56.
 
Bone structure assessed by HR-pQCT, TBS and DXL in adult patients with different types of osteogenesis imperfecta.
Kocijan R., Muschitz C., Haschka J., Hans D., Nia A., Geroldinger A., Ardelt M., Wakolbinger R., Resch H., 2015. Osteoporosis International : A Journal Established As Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa, 26 (10) pp. 2431-2440. Peer-reviewed.
 
Care related pain in rehabilitation after orthopedic trauma: An exploratory study with qualitative data.
Favre C., Dériaz O., Hanon R., Luthi F., 2015. Annals of Physical and Rehabilitation Medicine, 58 (3) pp. 132-138. Peer-reviewed.
 
Cranial neuropathies in granulomatosis with polyangiitis (Wegener's): a case-based review.
Söderström A., Revaz S., Dudler J., 2015. Clinical Rheumatology, 34 (3) pp. 591-596. Peer-reviewed.
Dendritic Cells Cause Bone Lesions in a New Mouse Model of Histiocytosis.
Grosjean F., Nasi S., Schneider P., Chobaz V., Liu A., Mordasini V., Moullec K., Vezzoni P., Lavanchy C., Busso N. et al., 2015. Plos One, 10 (8) pp. e0133917. Peer-reviewed.
 
Differences and similarities in rheumatology specialty training programmes across European countries.
Sivera F., Ramiro S., Cikes N., Dougados M., Gossec L., Kvien T.K., Lundberg I.E., Mandl P., Moorthy A., Panchal S. et al., 2015. Annals of the Rheumatic Diseases, 74 (6) pp. 1183-1187. Peer-reviewed.
Erratum to: A prospective evaluation of ultrasound as a diagnostic tool in acute microcrystalline arthritis.
Zufferey P., Valcov R., Fabreguet I., Dumusc A., Omoumi P., So A., 2015., Bibliomics (AP) - Changement de typage - article changé en "Autre" / ERRATUM.
 
Fracture Discrimination by Combined Bone Mineral Density (BMD) and Microarchitectural Texture Analysis.
Touvier J., Winzenrieth R., Johansson H., Roux J.P., Chaintreuil J., Toumi H., Jennane R., Hans D., Lespessailles E., 2015. Calcified Tissue International, 96 (4) pp. 274-283. Peer-reviewed.
High level of anti-drug antibodies after intra-articular injection of anti-TNF.
Zufferey P., Perreau M., So A., 2015. Rheumatology, 54 (12) pp. 2291-2292.
 
Imagerie par DXA: le couteau suisse multifonction [DXA imaging: the multifunction Swiss army knife?].
Gonzalez Rodriguez E., Favre L., Lamy O., Pralong F., Hans D., 2015. Revue Médicale Suisse, 11 (466) pp. 645-650. Peer-reviewed.
 
Interleukin-1 as a therapeutic target in gout.
Dumusc A., So A., 2015. Current Opinion in Rheumatology, 27 (2) pp. 156-163. Peer-reviewed.
 
Intracellular ATP Decrease Mediates NLRP3 Inflammasome Activation upon Nigericin and Crystal Stimulation.
Nomura J., So A., Tamura M., Busso N., 2015. Journal of Immunology, 195 (12) pp. 5718-5724. Peer-reviewed.
 
Maladie de Whipple: quand y penser [Whipple's disease, when to think about it?].
Cunningham S., Maulucci F., Zufferey P., Ribi C., Maillard M.H., 2015. Revue Médicale Suisse, 11 (484) pp. 1582, 1584-1582, 1586.
Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout.
McKinney C., Stamp L.K., Dalbeth N., Topless R.K., Day R.O., Kannangara D.R., Williams K.M., Janssen M., Jansen T.L., Joosten L.A. et al., 2015. Arthritis Research and Therapy, 17 p. 288. Peer-reviewed.
 
Pharmacokinetics in hepatic impairment: Mind the protein binding.
Chtioui H., Buclin T., 2015. Journal of Hepatology, 63 (6) pp. 1539-1540. Peer-reviewed.
 
Predictive ability of heel quantitative ultrasound for incident fractures: an individual-level meta-analysis.
McCloskey E.V., Kanis J.A., Odén A., Harvey N.C., Bauer D., González-Macias J., Hans D., Kaptoge S., Krieg M.A., Kwok T. et al., 2015. Osteoporosis International, 26 (7) pp. 1979-1987. Peer-reviewed.
 
Reproducibility of Vertebral Fracture Assessment Readings From Dual-energy X-ray Absorptiometry in Both a Population-based and Clinical Cohort: Cohen's and Uniform Kappa.
Aubry-Rozier B., Chapurlat R., Duboeuf F., Iglesias K., Krieg M.A., Lamy O., Burnand B., Hans D., 2015. Journal of Clinical Densitometry, 18 (2) pp. 233-238. Peer-reviewed.
 
Rhumatologie. Rhumatisme psoriasique [Update in psoriatic arthritis treatment].
Berner J., Zufferey P., 2015. Revue Médicale Suisse, 11 (456-457) pp. 139-142. Peer-reviewed.
Subjective perceptions as prognostic factors of time to fitness for work during a 4-year period after inpatient rehabilitation for orthopaedic trauma.
Vuistiner P., Luthi F., Erhart P., Scholz S.M., Dériaz O., 2015. Swiss Medical Weekly, 145 pp. w14235.
 
TBS reflects trabecular microarchitecture in premenopausal women and men with idiopathic osteoporosis and low-traumatic fractures.
Muschitz C., Kocijan R., Haschka J., Pahr D., Kaider A., Pietschmann P., Hans D., Muschitz G.K., Fahrleitner-Pammer A., Resch H., 2015. Bone, 79 pp. 259-266. Peer-reviewed.
 
Tendinopathie d'Achille [Achilles tendinopathy].
Berner J., Zufferey P., 2015. Revue Médicale Suisse, 11 (465) pp. 606-8, 610-1.
 
Tendinopathies du coude [Elbow tendinopathy].
Dumusc A., Zufferey P., 2015. Revue Médicale Suisse, 11 (465) pp. 591-595. Peer-reviewed.
 
Tendinopathies du sportif: étiologie, diagnostic et traitement [Tendinitis in athletes: etiology, diagnosis and treatment].
Gremion G., Zufferey P., 2015. Revue Médicale Suisse, 11 (465) pp. 596-601.
 
The importance of sonographer experience and machine quality with regards to the role of musculoskeletal ultrasound in routine care of rheumatoid arthritis patients.
Brulhart L., Ziswiler H.R., Tamborrini G., Zufferey P., SONAR/SCQM programmes , 2015. Clinical and Experimental Rheumatology, 33 (1) pp. 98-101. Peer-reviewed.
Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice.
Harvey N.C., Glüer C.C., Binkley N., McCloskey E.V., Brandi M.L., Cooper C., Kendler D., Lamy O., Laslop A., Camargos B.M. et al., 2015. Bone, 78 pp. 216-224. Peer-reviewed.
 
Treatment with tumor necrosis factor inhibitors in axial spondyloarthritis: comparison between private rheumatology practices and academic centers in a large observational cohort.
Ciurea A., Weber U., Stekhoven D., Scherer A., Tamborrini G., Bernhard J., Toniolo M., Villiger P.M., Zufferey P., Kissling R.O. et al., 2015. Journal of Rheumatology, 42 (1) pp. 101-105. Peer-reviewed.
 
Update on osteoporosis from the 2014 Santa Fe Bone symposium.
Lewiecki E.M., Bilezikian J.P., Binkley N., Hans D., Krueger D., Miller P.D., Oates M., Shane E., 2015. Endocrine Research, 40 (2) pp. 106-119. Peer-reviewed.
Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants.
Faraoni D., Levy J.H., Albaladejo P., Samama C.M., Groupe d'Intérêt en Hémostase Périopératoire, 2015. Critical Care, 19 p. 203.
Xanthine oxidoreductase regulates macrophage IL1β secretion upon NLRP3 inflammasome activation.
Ives A., Nomura J., Martinon F., Roger T., LeRoy D., Miner J.N., Simon G., Busso N., So A., 2015. Nature Communications, 6 p. 6555.
 
L'échographie dans la détection de la polyarthrite rhumatoïde précoce et le suivi de la polyarthrite rhumatoïde
Zufferey P., 2014/09. Rheuma Schweiz = Rheuma Suisse 5 pp. 18-20.
 
Dispensable role of myeloid differentiation primary response gene 88 (MyD88) and MyD88-dependent toll-like receptors (TLRs) in a murine model of osteoarthritis.
Nasi S., Ea H.K., Chobaz V., van Lent P., Lioté F., So A., Busso N., 2014/07. Joint, Bone, Spine : Revue du Rhumatisme, 81 (4) pp. 320-324.
 
Rôle de l'imagerie dans le diagnostic et le suivi de la polyarthrite rhumatoïde [Role of imaging in the diagnosis and follow-up of rheumatoid arthritis].
Zufferey P., Becce F., 2014/03. Revue Médicale Suisse, 10 (421) pp. 585-6, 588-9.
 
A meta-analysis of the association of fracture risk and body mass index in women.
Johansson H., Kanis J.A., Odén A., McCloskey E., Chapurlat R.D., Christiansen C., Cummings S.R., Diez-Perez A., Eisman J.A., Fujiwara S. et al., 2014. Journal of Bone and Mineral Research, 29 (1) pp. 223-233.
 
Are patterns of bone loss in anorexic and postmenopausal women similar? Preliminary results using high resolution peripheral computed tomography.
Milos G., Häuselmann H.J., Krieg M.A., Rüegsegger P., Gallo L.M., 2014. Bone, 58 pp. 146-150.
 
Calcium revisited: part II calcium supplements and their effects.
Lamy O., Burckhardt P., 2014. Bonekey Reports, 3 p. 579. Peer-reviewed.
 
Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study.
Senn C., Günther B., Popp A.W., Perrelet R., Hans D., Lippuner K., 2014. Osteoporosis International, 25 (7) pp. 1945-1951. Peer-reviewed.
 
Comparing Bone Microarchitecture by Trabecular Bone Score (TBS) in Caucasian American Women with and Without Osteoporotic Fractures.
Leib E., Winzenrieth R., Lamy O., Hans D., 2014. Calcified Tissue International, 95 (3) pp. 201-208. Peer-reviewed.
 
Complications et atteintes systémiques de la polyarthrite rhumatoïde [Complications and systemic manifestations of rheumatoid arthritis].
Dumusc A., So A., 2014. Revue Médicale Suisse, 10 (421) pp. 590, 592-590, 594.
 
Consensus interdisciplinaire CHUV-HUG sur la prise en charge des douleurs du dos. Son application lausannoise dans la filière du dos [Inter-hospital CHUV-HUG medical consensus of back pain management. Its application in care pathways within CHUV of Lausanne].
de Goumoens P., Genevay S., Tessitore E., Zaarour M., Duff J.M., Faundez A., Schizas C., Schindler M., Zoccatelli D., Foletti A. et al., 2014. Revue Médicale Suisse, 10 (428) pp. 970-973.
 
Consensus of Official Position of IOF/ISCD FRAX Initiatives in Asia-Pacific Region.
Wu C.H., McCloskey E.V., Lee J.K., Itabashi A., Prince R., Yu W., Li-Yu J., Chionh S.B., Zhao Y., Shin C.S. et al., 2014. Journal of Clinical Densitometry, 17 (1) pp. 150-155. Peer-reviewed.
Consistency of safety and efficacy of new oral anticoagulants across subgroups of patients with atrial fibrillation.
Lega J.C., Bertoletti L., Gremillet C., Chapelle C., Mismetti P., Cucherat M., Vital-Durand D., Laporte S., Meta-Embol Group, 2014. PLoS One, 9 (3) pp. e91398. Peer-reviewed.
 
Creation of an Age-Adjusted, Dual-Energy X-ray Absorptiometry-Derived Trabecular Bone Score Curve for the Lumbar Spine in Non-Hispanic US White Women.
Simonelli C., Leib E., Mossman N., Winzenrieth R., Hans D., McClung M., 2014. Journal of Clinical Densitometry, 17 (2) pp. 314-319. Peer-reviewed.
 
Cyclophosphamide: As bad as its reputation? Long-term single centre experience of cyclophosphamide side effects in the treatment of systemic autoimmune diseases.
Dan D., Fischer R., Adler S., Förger F., Villiger P.M., 2014. Swiss medical weekly, 144 pp. w14030. Peer-reviewed.
Double seronegative myasthenia gravis with antiphospholipid syndrome: a case report.
Dan D., Bart P.A., Novy J., Kuntzer T., Clair C., 2014. Journal of Medical Case Reports, 8 (1) p. 2. Peer-reviewed.
 
Effects of Exemestane and Tamoxifen Treatment on Bone Texture Analysis Assessed by TBS in Comparison With Bone Mineral Density Assessed by DXA in Women With Breast Cancer.
Kalder M., Hans D., Kyvernitakis I., Lamy O., Bauer M., Hadji P., 2014. Journal of Clinical Densitometry, 17 (1) pp. 66-71. Peer-reviewed.
 
Emerging therapies for gout.
Edwards N.L., So A., 2014. Rheumatic Diseases Clinics of North America, 40 (2) pp. 375-387. Peer-reviewed.
 
Evaluating spine micro-architectural texture (via TBS) discriminates major osteoporotic fractures from controls both as well as and independent of site matched BMD: the Eastern European TBS study.
Vasic J., Petranova T., Povoroznyuk V., Barbu C.G., Karadzic M., Gojkovic F., Elez J., Winzenrieth R., Hans D., CulaficVojinovic V. et al., 2014. Journal of Bone and Mineral Metabolism, 32 (5) pp. 556-562. Peer-reviewed.
 
Fractures atypiques du fémur: A propos de trois cas cliniques [Atypical fractures of the femur: apropos of 3 clinical cases].
Sanduloviciu M., Stoll D., Lamy O., Krieg M.A., Aubry-Rozier B., 2014. Praxis, 103 (16) pp. 939-944. Peer-reviewed.
 
Gonalgies: que faire en médecine de premier recours [Knee pain in ambulatory practice].
Kermode T., Cornuz J., Zufferey P., Pasche O., 2014. Revue Médicale Suisse, 10 (452) pp. 2238, 2240-2238, 2245. Peer-reviewed.
 
Improving cardiovascular and renal outcomes in gout: what should we target?
Richette P., Perez-Ruiz F., Doherty M., Jansen T.L., Nuki G., Pascual E., Punzi L., So A.K., Bardin T., 2014. Nature Reviews. Rheumatology, 10 (11) pp. 654-661. Peer-reviewed.
 
Indirect comparison meta-analysis of two enoxaparin regimens in patients undergoing major orthopaedic surgery. Impact on the interpretation of thromboprophylactic effects of new anticoagulant drugs.
Laporte S., Chapelle C., Bertoletti L., Lega J.C., Cucherat M., Zufferey P.J., Darmon J.Y., Mismetti P., META-EMBOL Group, 2014. Thrombosis and Haemostasis, 112 (3) pp. 503-510.
 
Insurance coverage of pediatric burns: Switzerland versus USA.
Deghayli L., Moufarrij S., Norberg M., Sheridan R., Raffoul W., de Buys Roessingh A., Hirt-Burri N., Applegate L.A., 2014. Burns, 40 (5) pp. 814-825.
 
Le syndrome douloureux régional complexe (algodystrophie) sous toutes ses formes [Complex regional pain syndrome (algodystrophy) and all its forms].
Luthi F., Konzelmann M., 2014/01. Revue Médicale Suisse, 10 (415) pp. 271-272.
Long-Term Remission of an Aggressive Sebaceous Carcinoma following Chemotherapy
Orcurto A., Gay B.E., Sozzi W.J., Gilliet M., Leyvraz S., 2014. Case Reports In Dermatology, 6 (1) pp. 80-84. Peer-reviewed.
 
Lumbar spine texture enhances 10-year fracture probability assessment.
Leslie W.D., Johansson H., Kanis J.A., Lamy O., Oden A., McCloskey E.V., Hans D., 2014. Osteoporosis International, 25 (9) pp. 2271-2277. Peer-reviewed.
 
Morphometric Vertebral Assessments via the Use of Dual X-ray Absorptiometry for the Evaluation of Radiographic Damage in Ankylosing Spondylitis: A Pilot Study.
Aubry-Rozier B., Hans D., Krieg M.A., Lamy O., Dudler J., 2014. Journal of Clinical Densitometry, 17 (1) pp. 190-194. Peer-reviewed.
 
Myeloid-related proteins 8 and 14 contribute to monosodium urate monohydrate crystal-induced inflammation in gout.
Holzinger D., Nippe N., Vogl T., Marketon K., Mysore V., Weinhage T., Dalbeth N., Pool B., Merriman T., Baeten D. et al., 2014. Arthritis and Rheumatology, 66 (5) pp. 1327-1339. Peer-reviewed.
 
Persistence of ultrasound synovitis in patients with rheumatoid arthritis fulfilling the DAS28 and/or the new ACR/EULAR RA remission definitions: results of an observational cohort study.
Zufferey P., Möller B., Brulhart L., Tamborrini G., Scherer A., Finckh A., Ziswiler H.R., 2014. Joint, Bone, Spine : Revue Du Rhumatisme, 81 (5) pp. 426-432. Peer-reviewed.
Predicting Non Return to Work after Orthopaedic Trauma: The Wallis Occupational Rehabilitation RisK (WORRK) Model.
Luthi F., Deriaz O., Vuistiner P., Burrus C., Hilfiker R., 2014. Plos One, 9 (4) pp. e94268. Peer-reviewed.
 
Rhumatologie. Une nouvelle option thérapeutique dans la prise en charge de l'inflammation chronique en rhumatologie: les inhibiteurs des janus kinases [A new therapeutical option for chronic inflammation in rheumatology: janus kinases inhibitors (JAK)].
Varisco P.A., So A., 2014. Revue Médicale Suisse, 10 (414) pp. 187-191.
Risks and benefits of percutaneous vertebroplasty or kyphoplasty in the management of osteoporotic vertebral fractures.
Lamy O., Uebelhart B., Aubry-Rozier B., 2014. Osteoporosis International, 25 (3) pp. 807-819.
Skeletal muscle mitochondria in the elderly: effects of physical fitness and exercise training.
Broskey N.T., Greggio C., Boss A., Boutant M., Dwyer A., Schlueter L., Hans D., Gremion G., Kreis R., Boesch C. et al., 2014. Journal of Clinical Endocrinology and Metabolism, 99 (5) pp. 1852-1861.
 
Spine bone texture assessed by trabecular bone score (TBS) predicts osteoporotic fractures in men: The Manitoba Bone Density Program.
Leslie W.D., Aubry-Rozier B., Lix L.M., Morin S.N., Majumdar S.R., Hans D., 2014. Bone, 67 pp. 10-14. Peer-reviewed.
 
Spine Bone Texture Assessed by Trabecular Bone Score (TBS) to Evaluate Bone Health in Thalassemia Major.
Baldini M., Ulivieri F.M., Forti S., Serafino S., Seghezzi S., Marcon A., Giarda F., Messina C., Cassinerio E., Aubry-Rozier B. et al., 2014. Calcified Tissue International, 95 (6) pp. 540-546. Peer-reviewed.
 
Spine trabecular bone score subsequent to bone mineral density improves fracture discrimination in women.
Krueger D., Fidler E., Libber J., Aubry-Rozier B., Hans D., Binkley N., 2014. Journal of Clinical Densitometry, 17 (1) pp. 60-65. Peer-reviewed.
 
The concept of the inflammasome and its rheumatologic implications.
So A., Busso N., 2014. Joint, Bone, Spine, 81 (5) pp. 398-402. Peer-reviewed.
The role of teriparatide in sequential and combination therapy of osteoporosis.
Meier C., Lamy O., Krieg M.A., Mellinghoff H.U., Felder M., Ferrari S., Rizzoli R., 2014. Swiss Medical Weekly, 144 pp. w13952. Peer-reviewed.
 
Trabecular bone score: a noninvasive analytical method based upon the DXA image.
Silva B.C., Leslie W.D., Resch H., Lamy O., Lesnyak O., Binkley N., McCloskey E.V., Kanis J.A., Bilezikian J.P., 2014. Journal of Bone and Mineral Research, 29 (3) pp. 518-530. Peer-reviewed.
 
Ultrasound evaluation of synovitis in RA: Correlation with clinical disease activity and sensitivity to change in an observational cohort study.
Zufferey P., Brulhart L., Tamborrini G., Finckh A., Scherer A., Moller B., Ziswiler H.R., 2014. Joint, Bone, Spine, 81 (3) pp. 222-227.
Utility of the trabecular bone score (TBS) in secondary osteoporosis.
Ulivieri F.M., Silva B.C., Sardanelli F., Hans D., Bilezikian J.P., Caudarella R., 2014. Endocrine, 47 (2) pp. 435-448. Peer-reviewed.
 
Vertebral microarchitecture and fragility fracture in men: a TBS study.
Leib E., Winzenrieth R., Aubry-Rozier B., Hans D., 2014. Bone, 62 pp. 51-55. Peer-reviewed.
Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice.
Nomura J., Busso N., Ives A., Matsui C., Tsujimoto S., Shirakura T., Tamura M., Kobayashi T., So A., Yamanaka Y., 2014. Scientific Reports, 4 p. 4554. Peer-reviewed.
 
Epaule douloureuse: prise en charge ambulatoire [Shoulder pain in ambulatory practice].
Kermode T., Pasche O., Cornuz J., Zufferey P., 2013/11. Revue Médicale Suisse, 9 (408) pp. 2205-8, 2210-1. Peer-reviewed.
 
La polymyalgia rheumatica en 2012
Buss G., Petitpierre S., Beer D., Zufferey P., Bart PA., 2013/09. Swiss Medical Forum, 13 (7) pp. 136-140.
 
The predictive value of trabecular bone score (TBS) on whole lumbar vertebrae mechanics: an ex vivo study.
Roux J.P., Wegrzyn J., Boutroy S., Bouxsein M.L., Hans D., Chapurlat R., 2013/09. Osteoporosis international, 24 (9) pp. 2455-2460. Peer-reviewed.
 
Periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome is linked to dysregulated monocyte IL-1β production.
Kolly L., Busso N., von Scheven-Gete A., Bagnoud N., Moix I., Holzinger D., Simon G., Ives A., Guarda G., So A. et al., 2013/06. The Journal of allergy and clinical immunology, 131 (6) pp. 1635-1643. Peer-reviewed.
 
Rôle du médecin interniste ou du généraliste dans le diagnostic et le suivi d'une collagénose [Family physician and connective tissue disorders].
Zufferey P., 2013/03. Revue Médicale Suisse, 9 (377) pp. 564-6, 568.
 
A pilot study of IL-1 inhibition in acute calcific periarthritis of the shoulder
Zufferey P., So A., 2013. Annals of the Rheumatic Diseases, 72 (3) pp. 465-467.
 
Acute heel pain related to apatite deposition in the plantar fascia.
Van Linthoudt D., Gerster J.C., 2013. Joint, Bone, Spine : Revue Du Rhumatisme, 80 (3) pp. 344-345.
Assessment of needs, health-related quality of life, and satisfaction with care in breast cancer patients to better target supportive care.
Brédart A., Kop J.L., Griesser A.C., Fiszer C., Zaman K., Panes-Ruedin B., Jeanneret W., Delaloye J.F., Zimmers S., Berthet V. et al., 2013. Annals of Oncology, 24 (8) pp. 2151-2158. Peer-reviewed.
Can one or two high doses of oral vitamin D3 correct insufficiency in a non-supplemented rheumatologic population?
Stoll D., Dudler J., Lamy O., Hans D., Krieg M.A., Aubry-Rozier B., 2013. Osteoporosis International, 24 (2) pp. 495-500.
Changing the awareness of low vitamin D status in a rheumatology population: a pre/post-study.
Stoll D., Lamy O., Hans D., Zufferey P., So A., Krieg M.A., Aubry-Rozier B., 2013. Swiss Medical Weekly, 143 pp. w13891.
 
Clinical factors associated with trabecular bone score.
Leslie W.D., Krieg M.A., Hans D., Manitoba Bone Density Program, 2013. Journal of Clinical Densitometry, 16 (3) pp. 374-379. Peer-reviewed.
 
Clinical images: enchondromatosis (Ollier disease).
Cerny M., Rudiger H.A., Aubry-Rozier B., Dugert E., Becce F., 2013. Arthritis and Rheumatism, 65 (11) p. 2886.
 
Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: results from the Swiss SCQM registry.
Zufferey P., Dudler J., Scherer A., Finckh A., 2013. Joint, Bone, Spine, 80 (2) pp. 160-164.
Do orthopaedic shoes improve local dynamic stability of gait? An observational study in patients with chronic foot and ankle injuries.
Terrier P., Luthi F., Dériaz O., 2013. Bmc Musculoskeletal Disorders, 14 (94) pp. 1-8.
Effects of anti-resorptive agents on trabecular bone score (TBS) in older women.
Krieg M.A., Aubry-Rozier B., Hans D., Leslie W.D., Manitoba Bone Density Program, 2013. Osteoporosis International, 24 (3) pp. 1073-1078.
 
Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: A three-year study.
Popp A.W., Guler S., Lamy O., Senn C., Buffat H., Perrelet R., Hans D., Lippuner K., 2013. Journal of Bone and Mineral Research, 28 (3) pp. 449-454.
Febuxostat, an Inhibitor of Xanthine Oxidase, Suppresses Lipopolysaccharide-Induced MCP-1 Production via MAPK Phosphatase-1-Mediated Inactivation of JNK.
Nomura J., Busso N., Ives A., Tsujimoto S., Tamura M., So A., Yamanaka Y., 2013. Plos One, 8 (9) pp. e75527.
How to regulate neutrophils in gout.
So A., 2013. Arthritis Research and Therapy, 15 (5) p. 118.
 
L'arthrose érosive des doigts [Erosive hand osteoarthritis].
Van Linthoudt D., Gabay C., So A.K., 2013. Revue Médicale Suisse, 9 (377) pp. 569-575.
 
Les connectivites, une affaire de spécialistes [Connective tissue diseases, a matter for specialists?].
Gabay C., So A., 2013. Revue Médicale Suisse, 9 (377) pp. 539-540.
 
Les connectivites: progrès thérapeutiques et place de la biothérapie [Connective tissue diseases: news in therapy, role of biologics agents].
Aubry-Rozier B., Fabreguet I., 2013. Revue Médicale Suisse, 9 (377) pp. 556-560.
 
Les douze points-clés de la rééducation après une prothèse totale de genou
Luthi F., Pereira L.C., Jolles B.M., 2013. Mains libres 2 pp. 71-78.
Pathogenic role of basic calcium phosphate crystals in destructive arthropathies.
Ea H.K., Chobaz V., Nguyen C., Nasi S., van Lent P., Daudon M., Dessombz A., Bazin D., McCarthy G., Jolles-Haeberli B. et al., 2013. Plos One, 8 (2) pp. e57352.
Polymyalgia rheumatica en 2012.
Buss G., Petitpierre S., Beer D., Zufferey P., Bart P.A., 2013. Forum Médical Suisse, 13 (7) pp. 136-140.
Recommendations for the use of ultrasound in rheumatoid arthritis: literature review and SONAR score experience.
Zufferey P., Tamborrini G., Gabay C., Krebs A., Kyburz D., Michel B., Moser U., Villiger P., So A., Ziswiler H.R., 2013. Swiss Medical Weekly, 143 pp. w13861.
Revisiting spatial distribution and biochemical composition of calcium-containing crystals in human osteoarthritic articular cartilage.
Nguyen C., Bazin D., Daudon M., Chatron-Colliet A., Hannouche D., Bianchi A., Côme D., So A., Busso N., Lioté F. et al., 2013. Arthritis Research and Therapy, 15 (5) pp. R103. Peer-reviewed.
 
Serous transformation of marrow of distal femoral epiphysis in a patient with congenital general lipodystrophy and spondylarthritis.
Zufferey P., Laredo J.D., 2013. Joint, Bone, Spine, 80 (6) p. 666. Peer-reviewed.
 
Serum uric acid and gout: from the past to molecular biology.
Punzi L., So A., 2013. Current Medical Research and Opinion, 29 (Suppl. 3) pp. 3-8.
 
Stages of change, barriers, benefits, and preferences for exercise in RA patients: a cross-sectional study
Henchoz Y., Zufferey P., So A., 2013. Scandinavian Journal of Rheumatology, 42 (2) pp. 136-145.
 
Targeting inflammasomes in rheumatic diseases.
So A., Ives A., Joosten L.A., Busso N., 2013. Nature Reviews. Rheumatology, 9 (7) pp. 391-399. Peer-reviewed.
 
TBS (trabecular bone score) and diabetes-related fracture risk.
Leslie W.D., Aubry-Rozier B., Lamy O., Hans D., Manitoba Bone Density Program, 2013. Journal of Clinical Endocrinology and Metabolism, 98 (2) pp. 602-609.
The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension.
Bone H.G., Chapurlat R., Brandi M.L., Brown J.P., Czerwinski E., Krieg M.A., Mellström D., Radominski S.C., Reginster J.Y., Resch H. et al., 2013. Journal of Clinical Endocrinology and Metabolism, 98 (11) pp. 4483-4492.
 
Three-Dimensional (3D) Microarchitecture Correlations with 2D Projection Image Gray-Level Variations Assessed by Trabecular Bone Score Using High-Resolution Computed Tomographic Acquisitions: Effects of Resolution and Noise.
Winzenrieth R., Michelet F., Hans D., 2013. Journal of Clinical Densitometry : the Official Journal of the International Society For Clinical Densitometry, 16 (3) pp. 287-296. Peer-reviewed.
 
Trabecular bone score improves fracture risk prediction in non-osteoporotic women: the OFELY study.
Boutroy S., Hans D., Sornay-Rendu E., Vilayphiou N., Winzenrieth R., Chapurlat R., 2013. Osteoporosis International, 24 (1) pp. 77-85. Peer-reviewed.
Trabecular bone score is associated with volumetric bone density and microarchitecture as assessed by central QCT and HRpQCT in Chinese American and white women.
Silva B.C., Walker M.D., Abraham A., Boutroy S., Zhang C., McMahon D.J., Liu G., Hans D., Bilezikian J.P., 2013. Journal of Clinical Densitometry, 16 (4) pp. 554-561. Peer-reviewed.
 
Trunk neuromuscular responses to a single whole-body vibration session in patients with chronic low back pain: a cross-sectional study.
Boucher J.A., Abboud J., Dubois J.D., Legault E., Descarreaux M., Henchoz Y., 2013. Journal of Manipulative and Physiological Therapeutics, 36 (9) pp. 564-571.
 
Two cases of Takayasu's arteritis occurring under anti-TNF therapy.
Mariani N., So A., Aubry-Rozier B., 2013. Joint, Bone, Spine, 80 (2) pp. 211-213.
 
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012.
Furst D.E., Keystone E.C., So A.K., Braun J., Breedveld F.C., Burmester G.R., De Benedetti F., Dörner T., Emery P., Fleischmann R. et al., 2013. Annals of the Rheumatic Diseases, 72 (Suppl. 2) pp. ii2-i34.
What was your fracture risk evaluated by FRAX(®) the day before your osteoporotic fracture?
Aubry-Rozier B., Stoll D., Krieg M.A., Lamy O., Hans D., 2013. Clinical Rheumatology, 32 (2) pp. 219-223.
Workshop report: 4th European crystal network meeting.
Lioté F., Merriman T., Nasi S., So A., 2013. Arthritis Research and Therapy, 15 (5) p. 304.
 
Atteintes de la chevill et du tarse postérieur dans les maladies métaboliques
Gerster JC., Zufferey P., 2012/06. Médecine et Chirurgie du Pied, 28 (2) pp. 54-58. Peer-reviewed.
Use of abatacept in rheumatoid arthritis.
von Kempis J., Dudler J., Hasler P., Kyburz D., Tyndall A., Zufferey P., Villiger P.M., 2012/05/11. Swiss medical weekly, 142 pp. w13581. Peer-reviewed.
Voriconazole-induced periostitis.
Rossier C., Dunet V., Tissot F., Aubry-Rozier B., Marchetti O., Boubaker A., 2012/02. European journal of nuclear medicine and molecular imaging, 39 (2) pp. 375-376. Peer-reviewed.
 
6 years' Denosumab treatment in postmenopausal women with osteoporosis: first 3 years of the FREEDOM Extension
Papapoulos S., Brown J.P., Bone H.G., Chapurlat R., Franchimont N., Brandi M.L., Czerwinski E., Krieg M.A., Man Z., Mellstrom D. et al., 2012. pp. S476-S477 dans 2012 IOF Regionals - 1st Latin America Osteoporosis Meeting, Osteoporosis International.
 
A controlled trial of the benefits of ultrasound-guided steroid injection for shoulder pain.
Zufferey P., Revaz S., Degailler X., Balague F., So A., 2012. Joint, Bone, Spine, 79 (2) pp. 166-169. Peer-reviewed.
 
A meta-analysis of the association between falls and hip fracture risk
McCloskey E.V., Kanis J.A., Oden A., Johansson H., Diez-Perez A., Jaeisman J.A., Nguyen T.V., Center J.R., Hans D., Krieg M.A. et al., 2012. pp. S80-S81 dans IOF-ECCEO 2012, 2nd European Congress on Osteoporosis and Osteoarthritis, Osteoporosis International.
 
A pilot study of the efficacy of IL1 blockade by anakinra in acute calcific periarthritis of the rotator cuff
Zufferey P., Faucherre M., Varisco P.A, Aubry B., Fabreguet I., So A.K., 2012. pp. S59 dans Annual Scientific Meeting of the American College of Rheumatology (ACR) and Association of Rheumatology Health Professionals (ARHP), Arthritis and Rheumatism.
 
Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial.
Genevay S., Finckh A., Zufferey P., Viatte S., Balagué F., Gabay C., 2012. Annals of the Rheumatic Diseases, 71 (4) pp. 560-562.
 
Améliorer la prescription d'un traitement hypolipémiant lors d'un syndrome coronarien aigu: absence de benefice d'une alerte automatique.
Genoud M., Hugli O., Rodondi N., Vogt P., Bardy D., Anex C., Dartiguenave F., Lamy. O. , 2012. pp. 58S-59S dans 80. Jahresversammlung der Schweizerischen Gesellschaft für Allgemeine Innere Medizin, Swiss Medical Forum = Forum Médical Suisse.
 
Arthrose--où allons-nous en 2012 [Osteoarthrosis--where are we going in 2012].
So A., Gabay C., 2012. Revue Médicale Suisse, 8 (332) p. 555.
 
Aspects thérapeutiques de la vitamine D: quels taux cibler avec quels traitements [Therapeutic goal of vitamin D: optimal serum level and dose requirements].
Lamy O., Aubry-Rozier B., Stoll D., 2012. Revue Médicale Suisse, 8 (360) pp. 2066-2071.
 
Barriers, benefits and preferences for exercise in RA patients: A cross sectional study.
Henchoz Yves, Zufferey Pascal, So Alexander, 2012. pp. S527-S528 dans Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Arthritis and Rheumatism.
 
Beneficial effects of PTH on spine bone mineral density (BMD) and microarchitecture (TBS) parameters in postmenopausal women with osteoporosis. A 2-year study
Guenther Beatrice, Popp Albrecht, Stoll Delphine, Rosier Berengere Aubry, Perrelet Romain, Kasalicky Petr, Hans Didier, Lippuner Kurt, 2012. pp. S565 dans Osteoporosis and Bone Conference, Osteoporosis International.
 
Beneficial effects of PTH on spine bone mineral density (BMD) and microarchitecture (TBS) parameters in postmenopausal women with osteoporosis: A 2-year study
Guenther Beatrice, Popp Albrecht W., Stoll Delphine, Rosier Berengere Aubry, Perrelet Romain, Hans Didier, Lippuner Kurt, 2012. pp. S332-S333 dans IOF-ECCEO European Congress on Osteoporosis and Osteoarthritis / 2nd IOF-ESCEO Pre-Clinical Symposium, Osteoporosis International.
 
Beneficial effects of strontium ranelate compared to alendronate on trabecular bone score in post menopausal osteoporotic women: A 2-year study
Hans D., Krieg M.A., Lamy O., Felsenberg D., 2012. pp. S266-S267 dans IOF-ECCEO 2012, 2nd European Congress on Osteoporosis and Osteoarthritis, Osteoporosis International.
 
Beneficial effects of zoledronate compared to placebo on spine bone mineral density (BMD) and microarchitecture (TBS) parameters in postmenopausal women with osteoporosis: a 3-year study
Popp A.W., Buffat H., Lamy O., Perrelet R., Hans D., Lippuner K., 2012. pp. S328 dans IOF-ECCEO 2012, 2nd European Congress on Osteoporosis and Osteoarthritis, Osteoporosis International.
 
BMD, MA estimation (TBS) and VFA extracted from a slingle DXA device in combination with CRF improve the identification of women at high risk of fracture: the OsteLaus Study.
O. Lamy O. , Krieg M.A., Metzger M., Aubry-Rozier B., Stoll D., Hans D., 2012. dans ASBMR 2012, Annual Meeting of the American Society for Bone and Mineral Research.
 
Bone mineral density (BMD) combined with micro-architecture parameters (TBS) significantly improves the indentification of women at high risk of fracture: the SEMOF cohort study
Popp A.W., Meer S., Krieg M.A., Perrelet R., Hans D., Lippuner K., 2012. pp. S327-S328 dans IOF-ECCEO 2012, 2nd European Congress on Osteoporosis and Osteoarthritis, Osteoporosis International.
 
Bone mineral density (BMD), micro-architecture estimation (TBS) and vertebral fracture assessment (VFA) extracted from a single DXA device in combination with clinical risk factors improve significantly the identification of women at high risk of fracture
Lamy O., Krieg M.A., Metzger M., Aubry-Rozier B., Stoll D., Hans D., 2012. pp. A23 dans Interdisziplinärer Fachkongress OSTEOLOGIE des Dachverbandes Osteologie (DVO), Osteologie.
 
Bone mineral density (BMD), micro-architecture estimation (TBS) and vertebral fracture assessment (VFA) extracted from a single DXA device in combination with clinical risk factors improve significantly the identification of women at high risk of fracture.
Lamy O., Krieg M.A., Metzger M., Aubry-Rozier B., Stoll D., Hans D., 2012. pp. S29 dans ECTS 2012, 39th Annual Congress of the European Calcified Tissue Society, Bone.
 
Can the trabecular bone score (TBS) be considered as a major clinical risk factor (CRF) of osteoporotic fractures? A meta-like analysis
Hans D., Winzenrieth R., Aubry-Rozier B., Stoll D., Lamy O., Krieg M.A., 2012. pp. S151 dans ECTS 2012, 39th Annual Congress of the European Calcified Tissue Society, Bone.
 
Can the trabecular bone score be considered as a major clinical risk factor of osteoporotic fractures? A meta-like analysis.
Hans D., Winzenrieth R., Aubry-Rozier B., Stoll D., Lamy O., Krieg M.A., 2012. pp. A34 dans Interdisziplinärer Fachkongress OSTEOLOGIE des Dachverbandes Osteologie (DVO), Osteologie.
 
Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions.
Schlesinger N., Alten R.E., Bardin T., Schumacher H.R., Bloch M., Gimona A., Krammer G., Murphy V., Richard D., So A.K., 2012. Annals of the Rheumatic Diseases, 71 (11) pp. 1839-1848. Peer-reviewed.
 
Comment améliorer la reproductibilité de lecture des VFA en dépistage clinique? la cohorte OsteoLaus.
Aubry-Rozier B., Krieg M.A., Lamy O., Hans D., Burnand B., 2012. pp. A318 dans 25e Congrès français de rhumatologie CNIT, Revue du Rhumatisme.
 
Cross-cultural adaptation, reliability, internal consistency and validation of the Spinal Function Sort (SFS) for French- and German-speaking patients with back complaints.
Borloz S., Trippolini M.A., Ballabeni P., Luthi F., Deriaz O., 2012. Journal of Occupational Rehabilitation, 22 (3) pp. 387-393. Peer-reviewed.
Delayed contrast-enhanced MRI of the coronary artery wall in takayasu arteritis.
Schneeweis C., Schnackenburg B., Stuber M., Berger A., Schneider U., Yu J., Gebker R., Weiss R.G., Fleck E., Kelle S., 2012. Plos One, 7 (12) pp. e50655. Peer-reviewed.
 
Denosumab treatment of postmenopausal women with osteoporosis for 6 years: results from the first 3 years of the FREEDOM extension
Papapoulos S., Brown J.P., Chapurlat R., Franchimont N., Brandi M.L., Czerwinski E., Krieg M.A., Man Z., Mellstrom D., Radominski S.C. et al., 2012. pp. S76 dans IOF-ECCEO 2012, 2nd European Congress on Osteoporosis and Osteoarthritis, Osteoporosis International.
 
Diagnostic et prise en charge des calcifications d'apatite dans les tendinopathies calcifiantes
Brulhart L., Zufferey P., 2012. Rheuma Suisse 4 pp. 9-12.
 
Diminution des appréhensions dans la lombalgie chronique : retour au travail accéléré
Norberg M., Norberg I., Schindler C., Belgrand L., 2012. pp. A49 dans 25e Congrès Français de Rhumatologie, Revue du Rhumatisme.
 
Dupuytren's Disease : New Perspectives
Moolenburg J.D., Rappoport G., 2012. Journal of Clinical Rheumatology and Musculoskeletal Medecine, 3 (1) pp. 27-36.
 
Effects of exemestane and tamoxifen treatments on bone quantity and quality in patient with breast cancer
Hadji P., Kalder M., Kauka A., Bauer M., Ziller M., Hans D., 2012. pp. S289-S290 dans IOF-ECCEO European Congress on Osteoporosis and Osteoarthritis / 2nd IOF-ESCEO Pre-Clinical Symposium, Osteoporosis International.
 
Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis. Results of a 2-year study.
Rizzoli R., Chapurlat R.D., Laroche J.M., Krieg M.A., Thomas T., Frieling I., Boutroy S., Laib A., Bock O., Felsenberg D., 2012. Osteoporosis International, 23 (1) pp. 305-315.
 
Effets bénéfiques du ranélate de strontium compare à l'alendronate sur le TBS chez les femmes ostéoporotiques ménopausées: une étude de 2 ans.
Hans D., Krieg M.A., Lamy O., Felsenberg D., 2012. pp. A238-A239 dans 25e Congrès français de Rhumatologie CNIT, Revue du Rhumatisme.
 
Efficacy and Safety of Canakinumab Vs Triamcinolone Acetonide in Patients with Gouty Arthritis Unable to Use Nonsteroidal Anti-Inflammatory Drugs and Colchicine, and On Stable Urate Lowering Therapy (ULT) or Unable to Use ULT
Bardin T., So A., Alten R., Bloch M., John M. R., Krammer G., Nebesky J. M., Tao A., Schlesinger N., 2012. pp. S811-S812 dans Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Arthritis and Rheumatism.
 
Evaluation de la sarcopénie de la personne agée par la bio-impédance spectroscopique [Multispectral bioimpedance and sarcopenia in the elderly].
Rivier E., Gauthier T., Krieg M.A., Cosnier R., Piessevaux I., Preiswerk S., Quinet P., Yersin N., Glauser C., Lamotte P. et al., 2012. Revue Médicale Suisse, 8 (334) pp. 698-704.
 
Evolution of Hypovitaminosis D Prevalence in a Swiss Rheumatology Outpatient Population: a pre-post Information Study
Aubry-Rozier B., Stoll D., Lamy O., Krieg M.A., Hans D., 2012. dans ASBMR 2012, Annual Meeting of the American Society for Bone and Mineral Research.
 
Faut-il traiter l'osteoporose liee a la thalassemie majeure: deux cas cliniques [Should we treat thalassemia-induced osteoporosis: two case reports].
Lucini M., Stoll D., Aubry-Rozier B., Lamy O., 2012. Praxis, 101 (20) pp. 1325-1329.
Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension.
Papapoulos S., Chapurlat R., Libanati C., Brandi M.L., Brown J.P., Czerwiński E., Krieg M.A., Man Z., Mellström D., Radominski S.C. et al., 2012. Journal of Bone and Mineral Research, 27 (3) pp. 694-701.
 
Fractures non traumatiques en fin de grossesse: s'agit-il toujours d'une ostéoporose? A propos de deux cas [Non-traumatic fractures at the end of a pregnancy: are there always of osteoporotic origin].
Monigel H., Stoll D., Aubry-Rozier B., Fetz G.L., Theumann N., Lamy O., 2012. Praxis, 101 (14) pp. 923-928.
 
Fractures non traumatiques liées à la grossesse et à l'allaitement : s'agit-il toujours d'une ostéoporose? A propos de 2 cas
Monigel H., Stoll D., Aubry-Rozier B., Lamy O., 2012. dans 80. Jahrestagung der Schweizerischen Gesellschaft für Allgemeine Innere Medizin.
 
FRAX in combination with microarchitecture estimation (TBS) showed the best vertebral fracture discrimination over stand-alone approaches: the OsteoLaus study
Lamy O., Krieg M. A., Stoll D., Aubry-Rozier B., Metzger M., Hans D., 2012. p. 665 dans IOF Regionals 2nd Middle East and Africa Osteoporosis Meeting / 6th Pan Arab Osteoporosis Congress (PAOC), Osteoporosis International.
 
Gout: why is this curable disease so seldom cured?
Doherty M., Jansen T.L., Nuki G., Pascual E., Perez-Ruiz F., Punzi L., So A.K., Bardin T., 2012. Annals of the Rheumatic Diseases, 71 (11) pp. 1765-1770.
 
High body mass index, adjusted for BMD, is a risk factor for fracture in women
Johansson H., Kanis J.A., Oden A., McCloskey E., Chapurlat R.D., Christiansen C., Cummings S.R., Diez-Perez A., Eisman J.A., Fujiwara S. et al., 2012. pp. S311-S312 dans IOF-ECCEO 2012, 2nd European Congress on Osteoporosis and Osteoarthritis, Osteoporosis International.
 
High prevalence of osteoporosis in Swiss women aged 60 and older: a 2-year pilot screening campaign.
Krieg M.A., Lamy O., Aubry-Rozier B., Stoll D., Hans D., Berthoud M., 2012. pp. S237 dans AGS 2012, Annual Scientific Meeting of the American Geriatrics Society, Journal of the American Geriatrics Society.
 
Imagerie et arthrose [Imaging in osteoarthritis].
Zufferey P., Theumann N., 2012. Revue Médicale Suisse, 8 (332) pp. 557-563.
 
Impact of etanercept-methotrexate therapy on patient-reported outcomes in rheumatoid arthritis patients with up to 12 months of symptoms.
Emery Paul, Wiland Piotr, Spieler Wolfgang, Dudler Jean, Gaylord Stefanie, Williams Theresa, Pedersen Ronald, Koenig Andrew S., Vlahos Bonnie, Kotak Sameer, 2012. pp. S160 dans Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Arthritis and Rheumatism.
 
In Memoriam: Sergio Ragi-Eis, MD, CCD, CDT (April 8, 1962-February 22, 2012).
Bilezikian J.P., Zerbini C., Lewiecki E., Borges J.L., Miller P.D., Hans D., Camargos B.M., McClung M., 2012. Journal of Clinical Densitometry, 15 (3) pp. 257-259.
 
In postmenopausal women with osteoporosis, denosumab significantly improved trabecular bone score (TBS), an index of trabecular microarchitecture
McClung M.R., Lippuner K., Brandi M.L., Kaufman J.M., Zanchetta J.R., Krieg M.A., Bone H.G., Chapurlat R., Didier H., Wang A. et al., 2012. pp. S832 dans Annual Scientific Meeting of the American College of Rheumatology (ACR) and the Association of Rheumatology Health Professionals (ARHP), Arthritis and Rheumatism.
 
Knochenanabole Therapie mit Teriparatid [Bone anabolic treatment with Teriparatide].
Lamy O., 2012. Therapeutische Umschau. Revue Thérapeutique, 69 (3) pp. 187-191.
 
Les douze points-clés de la rééducation après une prothèse totale de genou [The 12 keypoints for rehabilitation after total knee arthroplasty].
Luthi F., Pereira L.C., Jolles B.M., 2012. Revue Médicale Suisse, 8 (367) pp. 2438-2444.
 
Long-Term Safety of Canakinumab in Patients with Gouty Arthritis.
So Alexander, Alten Reike, Schumacher H. Ralph , Bloch Mark, Bardin Thomas, John Markus R., Krammer Gerhard, Nebesky Jan Michael, Tao Aiyang, Schlesinger Naomi, 2012. pp. S63 dans Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP).
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University